Cholesterol: Controversies and consensus over 100 years of persistent efforts
Hypercholesterolemia is one of the major risk factors for the development of cardiovascular disease. There are still controversies surrounding cholesterol and blood lipid management. To explore an effective way to better optimize blood lipid management, over the past century, experts in the blood li...
Main Author: | Shui-Ping Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2017-01-01
|
Series: | Cardiology Plus |
Subjects: | |
Online Access: | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2017;volume=2;issue=2;spage=4;epage=8;aulast=Zhao |
Similar Items
-
The Impact of Simvastatin on Lipidomic Markers of Cardiovascular Risk in Human Liver Cells Is Secondary to the Modulation of Intracellular Cholesterol
by: Yvette L. Schooneveldt, et al.
Published: (2021-05-01) -
From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01) -
A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccharum officinarum wax alcohols (Policosanol) on improvement of blood cholesterol
by: Ha-Rim Kim, et al.
Published: (2023-08-01) -
Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01) -
Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
by: Anja K. Johansen, et al.
Published: (2023-03-01)